Diabetic foot problem in Nepal.


Journal

Frontiers in endocrinology
ISSN: 1664-2392
Titre abrégé: Front Endocrinol (Lausanne)
Pays: Switzerland
ID NLM: 101555782

Informations de publication

Date de publication:
2023
Historique:
received: 15 08 2023
accepted: 18 10 2023
medline: 1 12 2023
pubmed: 29 11 2023
entrez: 29 11 2023
Statut: epublish

Résumé

Nepal is a developing country where diabetes is becoming a major health challenge due to its high prevalence of 8.5% affecting around 2 million people. Due to limited resources, there are many barriers to providing affordable and convenient diabetes care or regular screening for complications. There is no reliable data on incidence, prevalence, and complications of diabetic foot problems in Nepal. We conducted an online survey amongst senior physicians, who were members of 'Diabetes & Endocrine Association of Nepal' to assess their perception of diabetic foot problems in Nepal. Thirty-Eight physicians responded to the survey who saw a total of 17597 patients in the preceding month. They recalled seeing 647 with 'Diabetic Foot Ulcers', giving a crude Diabetic Foot Ulcer prevalence rate of 3.7%. They recalled seeing 2522 patients with painful neuropathy that required medical treatment, giving a crude painful neuropathy prevalence rate of 14.3%. A history of foot ulcer was present in an additional 578 patients. Previous minor amputation had been performed in 215 patients (1.2%) and major amputation in 135 patients (0.8%). Despite having expertise in various fields there is no dedicated multi-disciplinary diabetic foot clinic in Nepal. This survey shows that diabetic foot problems are abundant in Nepal and there is a need for structured multi-disciplinary approach for screening and treatment.

Identifiants

pubmed: 38027189
doi: 10.3389/fendo.2023.1277940
pmc: PMC10661256
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1277940

Informations de copyright

Copyright © 2023 Baral and Rajbhandari.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

J Vasc Surg. 2019 Sep;70(3):806-814
pubmed: 30850290
N Engl J Med. 2017 Jun 15;376(24):2367-2375
pubmed: 28614678
Lancet Glob Health. 2018 Nov;6(11):e1146-e1148
pubmed: 30196097
Cost Eff Resour Alloc. 2020 Oct 01;18:40
pubmed: 33013204
Health Policy Plan. 2018 May 1;33(4):474-482
pubmed: 29447397
Kathmandu Univ Med J (KUMJ). 2020 Jan.-Mar;18(69):38-41
pubmed: 33582686
Ann Med. 2017 Mar;49(2):106-116
pubmed: 27585063
Cureus. 2020 Jun 15;12(6):e8636
pubmed: 32685305
PLoS One. 2022 Jan 6;17(1):e0261518
pubmed: 34990481
BMJ Open. 2022 Feb 22;12(2):e060750
pubmed: 35193925
F1000Res. 2021 Jul 7;10:543
pubmed: 34621512
Int J Low Extrem Wounds. 2014 Sep;13(3):173-9
pubmed: 25122161

Auteurs

Suman Baral (S)

Department of Diabetes & Endocrinology Mediciti Hospital, Lalitpur, Nepal.

Satyan Rajbhandari (S)

Department of Diabetes & Endocrinology Lancashire Teaching Hospital, Chorley, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH